Clinical Trial Update: Efficacy of Lapaquistat Acetate Alone and With Ezetimibe in Subjects With Primary Dyslipidemia. [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the efficacy of Lapaquistat Acetate, alone and in combination with Ezetimibe, in adults with primary dyslipidemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyslipidemia
• Hypercholesterolemia

Drugs mentioned

• EZETIMIBE (EZETIMIBE)
• Lapaquistat Acetate (lapaquistat acetate)

Snippet

Sponsor: Takeda | Conditions: Hypercholesterolemia | Phase 3 | Status: COMPLETED